BioInvent International AB (publ) (STO:BINV)
27.80
-0.65 (-2.28%)
Jan 21, 2026, 12:49 PM CET
BioInvent International AB Employees
BioInvent International AB had 124 employees as of September 30, 2025. The number of employees increased by 9 or 7.83% compared to the same quarter last year.
Employees
124
Change
9
Growth
7.83%
Revenue / Employee
1.97M SEK
Profits / Employee
-2.61M SEK
Market Cap
1.87B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 124 | 9 | 7.83% |
| Jun 30, 2025 | 122 | 10 | 8.93% |
| Mar 31, 2025 | 118 | 9 | 8.26% |
| Dec 31, 2024 | 114 | 3 | 2.70% |
| Sep 30, 2024 | 115 | 7 | 6.48% |
| Jun 30, 2024 | 112 | 9 | 8.74% |
| Mar 31, 2024 | 109 | 7 | 6.86% |
| Dec 31, 2023 | 111 | 17 | 18.09% |
| Sep 30, 2023 | 108 | 15 | 16.13% |
| Jun 30, 2023 | 103 | 14 | 15.73% |
| Mar 31, 2023 | 102 | 16 | 18.60% |
| Dec 31, 2022 | 94 | 10 | 11.90% |
| Sep 30, 2022 | 93 | 8 | 9.41% |
| Jun 30, 2022 | 89 | 11 | 14.10% |
| Mar 31, 2022 | 86 | 12 | 16.22% |
| Dec 31, 2021 | 84 | 12 | 16.67% |
| Sep 30, 2021 | 85 | 12 | 16.44% |
| Jun 30, 2021 | 78 | 6 | 8.33% |
| Mar 31, 2021 | 74 | 5 | 7.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Hansa Biopharma AB | 135 |
| Oncopeptides AB | 80 |
| Egetis Therapeutics AB | 40 |
| Diamyd Medical AB | 39 |
| Genovis AB (publ.) | 36 |
| Vicore Pharma Holding AB | 29 |
| Xspray Pharma AB | 27 |
| Cantargia AB | 22 |
BioInvent International AB News
- 2 months ago - BioInvent International AB (FRA:BIX0) Q3 2025 Earnings Call Highlights: Strategic Focus Amidst ... - GuruFocus
- 2 months ago - Q3 2025 BioInvent International AB Earnings Call Transcript - GuruFocus
- 2 months ago - BioInvent International AB (publ) 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 2 months ago - BioInvent International AB (publ) (BOVNF) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Transgene and BioInvent's Oncolytic Virus BT-001 Shows Promising Antitumor Activity in Ongoing Phase I/IIa Trial in Solid Tumors that Failed Previous Treatments - Benzinga